MARKET

ACST

ACST

Acasti Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.4070
-0.0314
-7.16%
After Hours: 0.4199 +0.0129 +3.17% 19:50 04/16 EDT
OPEN
0.4191
PREV CLOSE
0.4384
HIGH
0.4200
LOW
0.3810
VOLUME
14.00M
TURNOVER
--
52 WEEK HIGH
1.220
52 WEEK LOW
0.1710
MARKET CAP
81.45M
P/E (TTM)
-1.3495
1D
5D
1M
3M
1Y
5Y
Global Hypertriglyceridemia Treatment Market Size, Share, Value, and Competitive Landscape 2024 .
Apr 15, 2021 (Heraldkeepers) -- Research ScopeThis report researches the worldwide Hypertriglyceridemia Treatment market size (value) in key regions like...
Heraldkeepers · 3d ago
8-K: Acasti Pharma Inc.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________ Form 8-K _____________________ CURRENT REPORT (EDGAR Online via...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 03/09 14:23
Acasti Pharma Provides Update on Recent Financing Activities
LAVAL, Quebec, March 08, 2021 (GLOBE NEWSWIRE) -- As required pursuant to the policies of the TSX Venture Exchange, Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST) is providing an update on the use of its “at-the market” equity o...
GlobeNewswire · 03/08 22:30
5 Penny Stocks To Watch This Week As Biotech Takes Spotlight
Penny Stocks · 03/07 15:46
4 Hot Penny Stocks Bouncing After Recent Market Sell-Off
Feb 24, 2021 (Penny Stocks via COMTEX) -- 4 Biotech Penny Stocks to Watch Right Now Over the past twelve months, interest in biotech penny stocks has...
Penny Stocks · 02/24 21:12
Best Penny Stocks Under $1? 3 For Your Watch List Today
Feb 24, 2021 (Penny Stocks via COMTEX) -- Are These Cheap Penny Stocks Worth The Risk Right Now? Most traders understand that penny stocks are shares of...
Penny Stocks · 02/24 21:11
Top Penny Stocks To Buy Now? 4 To Watch Today
Feb 24, 2021 (Penny Stocks via COMTEX) -- Monday, February 8th, marked a new week for penny stocks. Overall, the stock market saw a large bullish jump...
Penny Stocks · 02/24 21:11
Hypertriglyceridemia Treatment Market 2021: Industry Analysis, Geographical Segmentation, Drivers, Challenges, Trends Forecasts By 2027
Feb 15, 2021 (The Expresswire) -- Global “Hypertriglyceridemia Treatment Market” forecast 2027; research report analyzed the existing state of the market by...
The Express Wire · 02/15 12:46
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ACST. Analyze the recent business situations of Acasti Pharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ACST stock price target is 0.2521 with a high estimate of 0.2521 and a low estimate of 0.2521.
EPS
Institutional Holdings
Institutions: 38
Institutional Holdings: 6.27M
% Owned: 3.13%
Shares Outstanding: 200.12M
TypeInstitutionsShares
Increased
5
700.49K
New
10
2.34M
Decreased
1
2.00K
Sold Out
6
138.31K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.60%
Pharmaceuticals & Medical Research
+0.89%
Key Executives
Chairman/Independent Director
Roderick Carter
President/Chief Executive Officer/Director
Janelle D'Alvise
Chief Financial Officer
Brian Ford
Chief Operating Officer/Chief Scientific Officer
Pierre Lemieux
Other
Brian Groch
Independent Director
Jean-Marie Canan
Independent Director
Donald Olds
No Data
About ACST
Acasti Pharma Inc. is a biopharmaceutical company. The Company is focused on the research, development and commercialization of prescription drugs using omega-3 fatty acids derived from krill oil. It is developing a cardiovascular drug, CaPre (omega-3 phospholipid) for the treatment of hypertriglyceridemia. CaPre is a krill oil derived mixture containing polyunsaturated fatty acids (PUFAs), primarily composed of omega-3 fatty acids, principally eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). CaPre is designed to reduce triglycerides while also potentially providing beneficial effects on low-density lipoprotein (LDL) cholesterol (LDL-C) and high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with severe hypertriglyceridemia.

Webull offers kinds of Acasti Pharma Inc stock information, including NASDAQ:ACST real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACST stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ACST stock methods without spending real money on the virtual paper trading platform.